Litigation Details for Allergan USA, Inc. v. MSN Laboratories Private Limited (D. Del. 2019)

Allergan USA, Inc. v. MSN Laboratories Private Limited (D. Del. 2019)

Docket	1:19-cv-01727	Date Filed	2019-09-13
Court	District Court, D. Delaware	Date Terminated	2025-01-02
Cause	35:271 Patent Infringement	Assigned To	Richard Gibson Andrews
Jury Demand	None	Referred To
Parties	AUROBINDO PHARMA LTD.
Patents	10,188,632; 11,007,179; 11,090,291; 11,160,792; 11,229,627; 11,311,516; 6,251,910; 6,346,532; 6,525,060; 7,250,419; 7,265,124; 7,741,356; 7,786,158; 8,344,011; 8,425,934; 8,691,860; 9,115,091; 9,364,489; 9,675,587; 9,789,125
Attorneys	Ronald M. Daignault
Firms	Morris, Nichols, Arsht & Tunnell
Link to Docket	External link to docket

Details for Allergan USA, Inc. v. MSN Laboratories Private Limited (D. Del. 2019)

Date Filed	Document No.	Description	Snippet	Link To Document
2019-09-13				External link to document
2019-09-13	1	Complaint	'587 patent"), 9,789,125 ("the '125 patent"), and/or 10,188,632 ("the…860 patent, the '091 patent, the '489 patent, the '587 patent, the '125 patent, and…860 patent, the '091 patent, the '489 patent, the '587 patent, the '125 patent, and…860 patent, the '091 patent, the '489 patent, the '587 patent, the '125 patent, and…860 patent, the '091 patent, the '489 patent, the '587 patent, the '125 patent, and	External link to document
2019-09-13	140	Opinion - Memorandum Opinion	the ʼ489 patent”), 9,789,125 (“the ʼ125 patent”), 9,675,587 (“the ʼ587 patent”), and 10,188,632 (“the ʼ632…terms in U.S. Patent Nos. 8,691,860, 9,115,091, 9,364,489, 9,789,125, 9,675,587, and 10,188,632.. Signed by…Crystalline Form Patents are the ʼ860 patent, the ʼ091 patent, the ʼ489 patent, and the ʼ125 patent. The Abuse-Deterrent… terms in U.S. Patent Nos. 8,691,860 (“the ’860 patent”), 9,115,091 (“the ʼ091 patent”), 9,364,489 (“…Abuse-Deterrent Patents are the ʼ587 patent and the ʼ632 patent. The parties agreed on the constructions	External link to document